Kinnate Biopharma Inc.

Kinnate Biopharma Inc. - PE Ratioverified

KNTE

Price:

$2.65

Market Cap:

$124.99M

Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily focused on identifying and advancing small-molecule drugs that target kinase enzymes to treat cancers defined by specific genetic markers. The company's product pipeline includes: KIN-2787: An inhibitor of rapidly accelerated fibrosarcoma (RAF), currently being developed to treat patients with lung cancer, melanoma, and other forms of solid tumors. KIN-3248: A small-molecule kinase inhibitor designed to counteract cancer-associated genetic mutations in the fibroblast growth factor receptors, specifically FGFR2 and FGFR3. KIN004 Program: This program encompasses early-stage small-molecule research, including a Cyclin-D...[Read more]

Industry

Biotechnology

IPO Date

2020-12-03

Stock Exchange

NASDAQ

Ticker

KNTE

The PE Ratio as of June 2026 (TTM) for Kinnate Biopharma Inc. (KNTE) is -0.95

According to Kinnate Biopharma Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.95. This represents a change of -31.33% compared to the average of -1.39 of the last 4 quarters.

Kinnate Biopharma Inc. (KNTE) Historical PE Ratio (quarterly & annually)

How has KNTE PE Ratio performed in the past?

The mean historical PE Ratio of Kinnate Biopharma Inc. over the last ten years is -70.70. The current -0.95 PE Ratio has changed 34.82% with respect to the historical average. Over the past ten years (40 quarters), KNTE's PE Ratio was at its highest in in the September 2023 quarter at -0.54. The PE Ratio was at its lowest in in the December 2019 quarter at -107.76.

Quarterly (TTM)
Annual

Average

-70.70

Median

-28.73

Minimum

-221.63

Maximum

-0.98

Kinnate Biopharma Inc. (KNTE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Kinnate Biopharma Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = -0.98

Minimum Annual Increase = -82.30%

Minimum Annual PE Ratio = -221.63

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.98-58.43%
2022-2.36-72.72%
2021-8.64-82.30%
2020-48.81-65.58%
2019-141.80-36.02%

Kinnate Biopharma Inc. (KNTE) Average PE Ratio

How has KNTE PE Ratio performed in the past?

The current PE Ratio of Kinnate Biopharma Inc. (KNTE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.99

5-year avg

-40.52

10-year avg

-70.70

Kinnate Biopharma Inc. (KNTE) PE Ratio vs. Peers

How is KNTE’s PE Ratio compared to its peers?

Kinnate Biopharma Inc.’s PE Ratio is less than NGM Biopharmaceuticals, Inc. (-0.89), greater than Graybug Vision, Inc. (-4.23), greater than Decibel Therapeutics, Inc. (-1.95), greater than Paratek Pharmaceuticals, Inc. (-1.91), greater than Tourmaline Bio, Inc. (-18.09), less than aTyr Pharma, Inc. (-0.62), less than RVL Pharmaceuticals plc (-0.05), greater than Pardes Biosciences, Inc. (-1.36), less than Sesen Bio, Inc. (0.30), greater than Aadi Bioscience, Inc. (-2.63),

Build a custom stock screener for Kinnate Biopharma Inc. (KNTE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kinnate Biopharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kinnate Biopharma Inc. (KNTE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kinnate Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Kinnate Biopharma Inc.'s PE Ratio?

How is the PE Ratio calculated for Kinnate Biopharma Inc. (KNTE)?

What is the highest PE Ratio for Kinnate Biopharma Inc. (KNTE)?

What is the 3-year average PE Ratio for Kinnate Biopharma Inc. (KNTE)?

What is the 5-year average PE Ratio for Kinnate Biopharma Inc. (KNTE)?

How does the current PE Ratio for Kinnate Biopharma Inc. (KNTE) compare to its historical average?